The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s smart insulin pens market report forecasts the smart insulin pens market size to grow to $0.12 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Smart Insulin Pens Market Report 2023 – https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

Smart Insulin Pens Market Size Forecast
The global smart insulin pens market is expected to grow from $0.09 billion in 2022 to $0.10 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global smart insulin pens market size is expected to grow to $0.12 billion in 2027 at a CAGR of 6.2%.

North America held the largest smart insulin pens market share.

Key Smart Insulin Pens Market Driver ­– Increase The Demand For Smart Insulin Pens
For kids who need to take insulin during school time and visually impaired diabetic patients, an accurate dose of insulin can even be pre-set over the dosage dial which helps inaccurate delivery of dose at the time of injection. Echo Plus by Novo Nordisk which is a pediatric-friendly insulin pen allows even half-unit dosing with a maximum of 30 units. HumaPen Luxura HD from Lilly allows the delivery of insulin in half-unit increments and NovoPen Junior – Insulin Pen by Novo Nordisk can deliver highly accurate doses of insulin and finely adjusts small doses even half-unit increments. The accurate adjustments and delivery of doses of insulin can avoid either over-dosing or low-dosing of the drug which is expected to increase the demand for smart insulin pens and drive the market growth.

Request for A Sample Of The Global Smart Insulin Pens Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3090&type=smp

Key Smart Insulin Pens Market Trend – Developing Next Generation Of Smart Insulin Pens
The next generation of smart insulin pens goes far beyond memory storage. They help in calculating personalized doses, track glucose continuously, and connect with apps of smartphones to visualize the data. In September 2020, Medtronic plc introduced InPen™ that is integrated with Guardian Connect™ CGM data to manage their diabetes. It is the only FDA_cleared smart insulin pen for people on multiple daily injections. This enhances the ease of usage of smart insulin pens which is expected to boost the market.

Smart Insulin Pens Market Segment
1) By Type: First Generation Pens, Second Generation Pens (Bluetooth Enabled, USB Connected)
2) By End User: Hospitals & Clinics, Ambulatory Surgical Centres, Home Care Settings
3) By Usability: Prefilled, Reusable
4) By Application: Type 1 Diabetes, Type 2 Diabetes

Smart Insulin Pens Market Major Players and Strategies
Major players in the smart insulin pens market are Companion Medical, Eli Lilly and Company, Novo Nordisk A/S, Diamesco Co. Ltd., Emperra GmbH E-Health Technologies, Digital Medics Pvt Ltd., F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co. Ltd., and Bigfoot Biomedical.

In February 2020, Senseonics a US-based medical technology company that primarily focuses on the design, development, and commercialization of glucose monitoring products announced a partnership with Companion Medical. The partnership will benefit both companies by integrating Eversense® CGM System with the InPen™ smart system for accurate insulin delivery. Companion Medical is a US-based company that aims at achieving desirable diabetes outcomes and manufactured InPen™ which is the US first FDA-approved insulin pen.

The Smart Insulin Pens Global Market Report 2023 covers regional data on smart insulin pens market size, smart insulin pens market trends and drivers, opportunities, strategies, and smart insulin pens market competitor analysis. The countries covered in the smart insulin pens market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Smart insulin pens are insulin delivery devices that keep track of the volume, time, and type of dosage. These devices may also perform tasks such as generating reports to be shared with healthcare professionals.

View More Reports Related To The Smart Insulin Pens Market –
Insulin Drugs Global Market Report 2023
Smart Pills Global Market Report 2023
Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: